SLBST Pharma’s Post

We're thrilled to announce the release of our White Paper on drug development in endometriosis and adenomyosis. This report, titled  "Mind The Gap(s) - Moving Novel Drugs from Bench to Bedside", provides a strategic roadmap for innovative treatments in these common and often devastating diseases. https://bit.ly/47YprcX Key Highlights: • In-depth analysis of the challenges in developing new therapies  • Exploration of opportunities for non-hormonal, disease-modifying treatments • Insights into transforming reproductive health outcomes for affected women Our White Paper delves into the complexities of these often overlooked conditions which affect millions of women worldwide. By identifying critical gaps in research and development, it aims to catalyze innovations that significantly improve the quality of life for those suffering from endometriosis and adenomyosis. Why It Matters: • Endometriosis and adenomyosis affect over 10% of women of reproductive age • Both conditions can cause severe pain, heavy bleeding, and fertility issues Many thanks to our partner Catenion and to the many academic thought leaders, industry experts, entrepreneurs, and patients who contributed to this effort! Only your continued input and feedback have made this White Paper possible. Download the report now and join us in driving meaningful change. https://bit.ly/47YprcX #WomensHealth #Endometriosis #Adenomyosis #Innovation #Healthcare #DownloadNow Andrew Horne Christian Becker Desislava Rangelova Krina Zondervan Kelle Moley Yu Bagger Dr. Ana Rita da Costa Pascal Joly Dr. Ilkin Nehls Charlotte Edenius David Hail Mohaned Shilaih Gabriella Knoll Matthieu Lehmann Thomas Faustmann Anula Jayasuriya Chandra P. Leo Liliane Brunner Halbach Jessica Chung Elke Bestel Esther Nzenza Lois Hinman Nada (Osman) Hanafi Ulrich Granzer Viatcheslav Rakov Claire Kanony-Truc CLAUDIE SANCHEZ clément LAUR Andras Bauer Stephanie Capo Chichi Stephanie Sassman Steven Levitte

Artemis Women's Health Foundation have announced the release of their White Paper on drug development for treatment of Endometriosis and adenomyosis. 📝The paper explores the complexities of these frequently overlooked conditions that impact millions of women globally. By highlighting key gaps in research and development, it seeks to drive innovations that can greatly enhance the quality of life for those affected. 👩⚕️Really exciting developments in the space, read more below!⬇️ #endometriosis #adenomyosis #womenshealth #femtech #artemiswomenshealthfoundation #whitepaper

📢 We’re back from Boston after a fantastic 4th convening of the Reproductive Health Innovation Summit! ❄ Not even a snowstorm could stop this community of entrepreneurs, investors, and leaders from coming together with the united goal of driving sector growth across reproductive health! 💡 Over the course of two days, there were panel discussions, presentations, networking, roundtables, and not one, but TWO innovation showcases with live Q&A! Industry experts led the way with their invaluable insights during the discussions, while the networking and intimate sessions were a fantastic way to connect with like-minded peers and forge partnerships. 💥 If I were to summarize the main takeaways from the summit in three words, they would be ACTION, ACCESS, and TECHNOLOGY…In every conversation I was engaged in, there was a collective drive to develop tangible and proactive action points needed to address the most pressing areas in reproductive health. Access was one of the biggest factors to consider as part of this drive towards action. Technology proved to be one of the most exciting opportunity areas to take action to drive access. ❤️ Thank you so much to this amazing industry for getting involved! Ferring Pharmaceuticals EMD Serono, Inc. Organon Premier Research Nixon Peabody LLP Future Fertility Presagen Hello Helio Women's Health Innovation Series #RHIS #reproductivehealth #womenshealth P.S. I had so much fun networking and getting stuck in that I only managed to get in one photo! Must be the sign of a great summit. 😉

🚀 The QLD Government is now offering 10 days of reproductive health care leave to all publicly owned energy companies! This means workers can access essential treatments for endometriosis, dysmenorrhea, vasectomies, IVF, and reproductive cancer screenings. As a woman who battles endometriosis daily, this is a HUGE win for the sector! 🎉 This isn't my usual post, but it's certainly one to celebrate and something I am personally passionate about. This policy enhances the benefits offered by publicly owned corporations. I wonder if any private sector companies will follow suit? This could set a new standard for supporting employees' reproductive health. “Employees will have access to up to 10 days per annum (non-cumulative) paid reproductive health leave to use for the following purposes: -For each parent to receive fertility/IVF treatment; -Chronic reproductive health conditions (such as endometriosis, dysmenorrhea, adenomyosis, polycystic ovary syndrome, and menopause symptoms) that require absence from the workplace;The policy will also provide for flexibility to manage symptoms at work. -Preventative screening associated with reproductive health, including breast and prostate screening (capped at 4 hours per year); -Treatment associated with reproductive health including hysterectomy and vasectomy.” For more information please follow the link ➡ https://lnkd.in/gygmppNY #FairEnergy #HealthierWorkplaces #SupportingWorkers #femaleworks #reproductivehealth

🎧 Exciting Episode Alert! This weeks episode of "She Leads Biotech" features the inspiring Sabrina Johnson President & CEO of Daré Bioscience, Inc. Grab a coffee and join us as we discuss the profound impact of offering more options and fostering open conversations in women's healthcare. Sabrina also shares the unique challenges and successes of founding a company dedicated to advancing women’s health. She highlights the importance of diversity in leadership and the urgent need for innovation in areas like contraception, arousal disorders, and menopause. Don't miss this insightful conversation! 🔗 Link to the episode in comments #SheLeadsBiotech #womeninbiotech #biotechnology #womenshealth

📢 New Report on Endometriosis & Adenomyosis Drug Development 📢 How wonderful it is to read this timely and impactful report from Artemis Women's Health Foundation and contributors such as Kelle Moley “Mind The Gap(s) - Moving Novel Drugs from Bench to Bedside”, which offers a strategic roadmap for developing innovative therapies for endometriosis and adenomyosis. These diseases impact over 10% of women of reproductive age, often resulting in debilitating pain, heavy bleeding, and fertility challenges💡 The White Paper provides: 🔬 In-depth analysis of the key challenges in drug development, focusing on the need for non-hormonal, disease-modifying treatments. 💼 Opportunities for innovative therapies that could transform reproductive health outcomes. 📈 Actionable insights to address critical research gaps, aimed at improving the quality of life for millions of women. As endometriosis and adenomyosis have historically been under-researched, this report calls for collaboration across academia, industry, and patient groups to bridge these gaps🤝 It’s a must-read for anyone invested in advancing women’s health🌍 Join the conversation by downloading the full report here https://lnkd.in/du8g4ipV and help drive innovation in women’s healthcare! ✊🏼✨ #Endometriosis #Adenomyosis #WomensHealth #DrugDevelopment #ReproductiveHealth #NonHormonalTherapies #Biotech

🚀 🚀 Launch announcement: 26k lines of code + 2 months + >250 medical repositories = Instant consultations, care and follow-ups for 97% of reproductive health issues! 🆕 Pinky Promise is proud to announce its new platform, which enables women to instantly consult with one of our Gynecologists, who assisted by our AI/ML, is able to prescribe in minutes for almost every single reproductive health symptom! It doesn't end there though... 👩⚕️ Even after getting a prescription, you can continue to chat with your doctor for free for 24 hours and keep paying for each additional day. The doctor's responses are quick and empathetic as we have trained a ChatGPT co-pilot for them. 🥇 We have successfully built the first ever consumer facing healthcare app that is able to almost instantly not only provide an 'assessment' of symptoms, but actually connect you to a doctor instantly and ensure you are able to take whatever medicines or care is needed to feel better, thereby closing the care loop with no wait times or uncertainty. 💡 This is just the beginning! We are able to predict and personalize your care and also build tools for providers and the larger ecosystem so womens health no longer suffers from a lack of data, research, understanding and innovation! 🎉 We are revolutionizing healthcare, starting with women. We are ending waiting times, poor care experiences, high price points, the need for multiple visits and most importantly, the tendency to seek care only when something is 'wrong'. Check us out here on https://bit.ly/3w4Z2LJ Onwards and upwards, ladies! Team Pinky Promise: Akanksha Vyas Dr. Reema Shah Feya Shah Anam Sajan Shreeya Sethi Hansika Jhawar Divya Balaji Kamerkar

#ICYMI - Yes, Biotechnology Innovation Organization did put the spotlight on women’s health, with the Growth Opportunities in Women’s Health panel discussion that 3Daughters CEO Mary Beth Cicero participated in at the 2024 BIO International Convention. The panel, moderated by Sheila Ann Mikhail, did a deep dive into the report from the McKinsey Health Institute on women’s health investments, to which fellow panelist Megan Greenfield, Ph.D. contributed. This lively discussion shed light on the challenges and opportunities in women's health, highlighting the crucial need for collective action to address gaps in research, funding, and increasing investor interest.    With proper funding, we can drive meaningful change and unlock the full potential of women's health. Let's pave the way for a future where every woman has access to the care and support that she deserves.    Shout out to Biotechnology Innovation Organization for their focus and support of women’s healthcare and for uplifting new companies like 3Daughters who are developing innovative technologies. Our thanks and appreciation go to Elizabeth G., Vice President of Membership at BIO, and Derek Scholes, Vice President of Science & Regulatory Affairs at BIO, who were instrumental in encouraging 3Daughters to participate.     🌟 3Daughters is developing a new frameless nonhormonal IUD to address insertion pain that keeps women from adopting one of the most effective forms of birth control. 🌟   #WomensHealth #Innovation #Contraception  #BIO2024   Click the link for deep dive into this vital conversation:   https://lnkd.in/ePPyEMB8 Read the full report from McKinsey: https://lnkd.in/efiUk-eT

🚀 We released Pinky Promise v2 this week 🚀. This is one of the most unique and challenging things I have built to date. I am very excited to see it go out into the world. In Jan 2023 Pinky Promise launched a basic version of this product covering three of the most commonly occurring reproductive health issues, and in one year we consulted for over 10K patients. Using many lessons from this, in the last two months we have expanded to 97% of all reproductive healthcare issues. Here are some of the big changes and the technologies behind this: 1. 🏥 Using over 250 of the top medical protocols in the world, carefully curated by our medical team, we are fine-tuning top medical LLM algorithms to create a medical decision making system biased towards women. Our patients come on the app and start by describing their symptoms, and within 5-10 mins of starting they have a Doctor-approved prescription in hand. We track Doctor edits and patient cure-rates to feed data back into this system and keep it improving. 2. 👩🏼⚕️ Once the patient receives the prescription, they are connected with their Doctor over chat throughout their care journey. To enable Doctor's to reply in near-realtime, we have built a Chat-GPT based copilot which suggests answers to all the Patient's questions. 3. 📱 We have rebuilt our app on flutter and is now available on Web, Android and iOS. 4. 💬 One of our biggest learnings so far has been that our target market is most comfortable with "chat". This product has been build on top of DialogFlow as a chatbot. Whether they are describing their symptoms or answering questions about their medical history, or booking tests - they can just chat with us. This sets the stage to seamlessly expand setting to provide instant reatime care on any platform (whatsapp / Alexa / sms) and across languages in the future. This is a launchpad for us. We are fast expanding our offerings to provide tools for the larger medical ecosystem and enable are patients to manage their health in an easy and cohesive manner that is anxiety free and proactive. Indian women don't go to Doctor's (including me). This is a huge step towards changing that. A huge huge shoutout to Divya Balaji Kamerkar, Dr. Reema Shah, Feya Shah, Shreeya Sethi, Anam Sajan, the entire Flair Labs team for pulling this off in record time! Do check it out we would love feedback and to chat about this journey! https://lnkd.in/d2juWaRd

🗣️There is still a great deal to learn regarding endometriosis. If you’re a scholar, investigator, clinician, grad student or patient advocate, then please consider sharing your expertise and/or experience ahead of the 4th Annual Endometriosis Conference. The 🌎 needs to hear from you!!! #endometriosis #research #breakingnewground